<DOC>
	<DOCNO>NCT01759849</DOCNO>
	<brief_summary>To examine effect block signal β-chain viability , activation differentiation eosinophils progenitor collect sputum , blood bone marrow sample collect pre post-allergen challenge mild atopic asthmatic subject .</brief_summary>
	<brief_title>CSL311 Cell Viability Asthma</brief_title>
	<detailed_description>The experiment use sputum sample induce subject mild asthma , undergo allergen inhalation challenge . In general , sample compose &gt; 10 % neutrophils &gt; 10 % macrophage . Samples collect pre-allergen low frequency eosinophil lymphocytes ( &lt; 1 % ) , however percentage eosinophils increase approximately 12 % follow allergen challenge . The sputum sample process DPBS ( without dithiothreitol ) , cell suspension adjust 1 million cells/ml DMEM penicillin streptomycin . A cytospin make differential cell count . The mixed cell population 5 million cells/ml incubate 48 hour 37 degree Celcius ± β-chain MAb concentration 100 mcg/ml . After 48 hour cell culture medium remove assay cytokine chemokines ELISA . Cells resuspend PBS Binding Buffer ( BD Pharmingen , Cat . 556454 ) , stain assessment flow cytometry , analyzed duplicate . Experiments use blood ( 80 ml ) bone marrow aspirate ( 5ml ) atopic asthmatic take pre 24hr post allergen challenge . Methylcult micro-culture colonogenic assay perform enumerate outgrowth Eo/Baso-CFU GM-CFU CD34+ cell population collect blood bone marrow sample . Methylcult assay perform CD34+ enrich cell population presence IL-5 , IL-3 GM-CSF +/- CSL311 . Following 14 day culture , colony enumerate .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Male female volunteer 18 65 year age . General good health Mild moderate , stable , allergic asthma History episodic wheeze shortness breath ; FEV1 baseline least 70 % predict value Able understand give write informed consent sign write informed consent form approve investigator 's REB Positive methacholine challenge Positive skinprick test common aeroallergens ( include cat , dust mite , grass , pollen ) Positive allergeninduced airway bronchoconstriction ( fall FEV1 least 20 % baseline ) A worsen asthma respiratory tract infection within 6 week precede study entry Use corticosteroid , immunosuppressive , anticoagulant ( warfarin heparin ) within 28 day prior randomization study Use nonsteroidal antiinflammatory drug ( NSAIDs ) within 48 hour dose aspirin 7 day dose Have chronic use medication treatment allergic lung disease short intermediateacting ß2agonists ipratropium bromide Use caffeinecontaining product medication 12 hour alcohol counter drug include aspirin , cold allergy medication 48 hour inhale bronchodilator 8 hour prior methacholine allergen challenge Use tobacco product kind currently within previous 12 month , smoke history &gt; 10 pack year . Lung disease mild moderate allergic asthma Unwillingness inability comply study protocol reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Asthma</keyword>
	<keyword>β-chain signaling</keyword>
	<keyword>allergen inhalation challenge</keyword>
	<keyword>sputum</keyword>
	<keyword>bone marrow aspirate</keyword>
	<keyword>blood collection</keyword>
	<keyword>-methacholine challenge</keyword>
</DOC>